Japan Securities Watchdog to Boost Monitoring of Biotech StocksBy and
SESC has noticed information leaks in the health industry
Will scrutinize trading when drug trial results are released
Japan’s securities watchdog will boost monitoring of health-care stocks for possible insider trading after noticing an increase in leaks of potentially market-moving information, according to the top official of the Securities and Exchange Surveillance Commission.
To continue reading this article you must be a Bloomberg Professional Service Subscriber.
If you believe that you may have received this message in error please let us know.